The disease can happen any time now
In India, a disease once governed by the rhythms of monsoon rains is learning to ignore the calendar. Dengue fever, long understood as a seasonal visitor arriving with the rains and departing with the cold, is now appearing in February and March — months that once offered a kind of biological reprieve. Driven by rising temperatures, urban sprawl, erratic rainfall, and the compounding burden of air pollution, the transmission window is widening, and a nation of over a billion people is being asked to hold a new understanding: that the threat does not rest.
- India recorded nearly 7,000 dengue cases before February 2026 had even ended — surpassing what entire pre-monsoon periods once looked like, and signaling that the disease's seasonal contract with the calendar has broken down.
- Southern states like Tamil Nadu and Maharashtra are bearing the heaviest early-season burden, but the geographic and temporal spread of the disease is moving in one direction: outward.
- A 2026 study found that countries with high air pollution suffer dengue death rates three to five times higher than cleaner-air nations, adding a toxic layer to an already complex crisis — one that India, with its severe PM2.5 levels, cannot ignore.
- Three vaccine candidates are in late-stage trials, including India's first indigenous single-dose option, but public health experts warn that no injection alone can outpace a disease reshaping itself around climate and urbanization.
- Hospitals, surveillance systems, and ordinary citizens are being asked to abandon the monsoon-only mindset and maintain vigilance across all twelve months — a cultural and logistical shift as significant as any medical intervention.
Nitin Sharma, a 32-year-old software engineer in Gurugram, fell ill in May — weeks before the monsoon arrived. His family never considered dengue. It was the wrong season. By the time a blood test confirmed the diagnosis, he had lost days to a false assumption, and two weeks of weakness followed the fever's end. What unsettled him most was not the illness but its timing. "Earlier, if someone had a fever in April, dengue would have been the last thing we thought about," he said.
Across India, doctors are watching that assumption collapse. Cases are now appearing in February, March, and April — months that once saw near-zero transmission. By the end of February 2026, India had already logged 6,927 dengue cases, exceeding the full January-to-May totals from 2021. The disease's familiar arc — rising with the monsoon, peaking after heavy rains, fading in the cool — is fracturing. Scientists point to rising temperatures, erratic rainfall, and rapid urbanization as the forces extending mosquito breeding windows and pushing the disease into new seasons and geographies. Tamil Nadu alone accounts for nearly 3,000 cases so far this year.
The annual death toll tells its own story: 485 lives lost in 2023, 297 in 2024, 131 in 2025. The year-on-year decline tempts optimism, but epidemiologists urge caution — partial immunity after large outbreaks temporarily suppresses transmission before new serotypes emerge and the cycle resumes. The long-term trajectory of dengue's range, both geographic and seasonal, continues to expand.
A 2026 study added another dimension to the crisis, finding that nations with high PM2.5 air pollution suffer dengue death rates three to five times higher than those with cleaner air. India's pollution levels far exceed WHO thresholds, and long-term exposure to fine particulate matter appears to weaken the immune and vascular systems — making dengue infections more severe when they arrive.
India is building its defenses. Takeda's Qdenga vaccine has been approved and is being produced locally, while two additional candidates — including DengiAll, India's first indigenous single-dose option — are completing Phase III trials. All three target all four dengue serotypes circulating simultaneously in India. But experts are unambiguous: vaccines are one tool among many. Vector control, sanitation, surveillance, and public awareness must all operate year-round now, not just during the rains.
Back in Gurugram, Sharma checks his flower pots and water containers every week, keeps repellent in the house regardless of the month, and no longer waits for the monsoon to begin worrying. "It feels like the disease can happen any time now," he said. For millions of Indians, that quiet reckoning is becoming the new baseline.
Nitin Sharma felt the fever coming on in May, weeks before the monsoon rains would arrive in India. The 32-year-old software engineer in Gurugram, the business district sprawling outside New Delhi, assumed it was nothing serious—a routine seasonal virus, the kind that passes quickly when the weather shifts. His family didn't even consider dengue. Why would they? Dengue was a monsoon disease. Everyone knew that. By the time a blood test confirmed dengue fever, Sharma had already spent days assuming he had something ordinary. The weakness lingered for two weeks after the fever broke, and what struck him most was not the illness itself but its timing. "Earlier, if someone had a fever in April, dengue would have been the last thing we thought about," he said later.
Across India's hospitals, doctors are seeing Sharma's experience repeat with increasing frequency. Cases are appearing in February, March, and April—months when dengue transmission has historically been nearly dormant. By the end of February 2026, India had already recorded 6,927 dengue cases, a figure that exceeded the entire January-to-May total from 2021 and was rapidly approaching the early-season burden of 2022. For decades, dengue followed a predictable rhythm: cases would climb during the monsoon, peak in the weeks after heavy rains, then fade as temperatures cooled. That pattern is fracturing. Hospitals in multiple states began reporting dengue infections weeks before the monsoon officially reached Kerala last year, signaling what scientists describe as a fundamental shift in how the disease behaves.
The culprits are familiar but accelerating: rising temperatures, erratic rainfall patterns, and the relentless sprawl of urban areas. These forces are creating longer breeding windows for the mosquitoes that carry dengue and allowing them to survive and spread farther than before. "Dengue is no longer restricted to the post-monsoon period," said Dr. Harshdeep Joshi, a professor of community medicine in Haryana. "We are increasingly seeing cases outside the traditional season. The transmission window appears to be expanding." The southern states have been hit hardest so far this year—Tamil Nadu alone accounts for 2,873 cases, followed by Maharashtra with 786, Kerala with 670, and Karnataka with 560. These regions benefit from warmer climates and longer mosquito breeding seasons, but the pattern is spreading. Public health officials who once prepared surveillance systems mainly during the rainy months now say hospitals and health workers must remain alert almost year-round.
The broader numbers tell a story of a disease that has become endemic to India's public health landscape. In 2023, the country recorded 289,235 dengue cases and 485 deaths—the highest annual burden in recent history. The following year brought 233,519 cases and 297 deaths. In 2025, the count dropped to 121,824 cases and 131 deaths, a decline that some observers initially interpreted as good news. But epidemiologists caution against reading too much into year-to-year fluctuations. After major outbreak years, partial immunity develops in affected populations, temporarily suppressing transmission. New serotypes emerge. Local environmental conditions shift. These short-term drops do not interrupt the long-term expansion of dengue's geographic and seasonal range, which continues to widen.
A separate threat compounds the problem. A 2026 study published in Environmental Pollution examined dengue data from 20 endemic countries between 2020 and 2024 and found a stark association between air pollution and dengue mortality. Countries with higher levels of PM2.5—fine particulate matter small enough to penetrate deep into the lungs and enter the bloodstream—recorded dengue death rates three to five times higher than countries with cleaner air. The World Health Organization recommends annual PM2.5 exposure limits of 5 micrograms per cubic metre; most high-burden countries in the study far exceeded this threshold. Long-term exposure to fine particulate pollution appears to weaken immune and vascular systems, and in dengue-endemic regions, this may significantly increase both the severity and fatality of infections when combined with climate and socioeconomic stress.
India is moving to develop defenses. Earlier this year, the government approved Takeda's dengue vaccine, Qdenga, which the company is producing locally through a partnership with Biological E, a Hyderabad-based manufacturer. The Indian Council of Medical Research and Panacea Biotec completed Phase III trial enrollment for DengiAll, India's first indigenous single-dose dengue vaccine candidate, involving 10,335 volunteers across the country. The Serum Institute of India is conducting Phase III trials for TetraVax-DV. All three candidates aim to protect against all four dengue serotypes—DENV-1, DENV-2, DENV-3, and DENV-4—which all circulate in India simultaneously, making multi-strain protection essential to prevent reinfections and severe disease.
But experts are clear that vaccines alone will not solve the problem. "Even with an effective vaccine, vector control and surveillance will remain critical," said Dr. Gagandeep Kang, a former professor at the Christian Medical College in Vellore. There is, as one public health consultant put it, "no single solution." Vector control, sanitation, disease surveillance, public awareness, and stronger healthcare systems all remain essential. Back in Gurugram, Sharma has changed his habits. He keeps mosquito repellents at home throughout the year now and regularly checks flower pots, rooftop tanks, and water containers for stagnant water, regardless of the season. "It feels like the disease can happen any time now," he said. For millions of Indians, that realization is becoming the new normal.
Citações Notáveis
Dengue is no longer restricted to the post-monsoon period. We are increasingly seeing cases outside the traditional season. The transmission window appears to be expanding.— Dr. Harshdeep Joshi, professor of community medicine, Maharishi Markandeshwar Medical College and Hospital
Even with an effective vaccine, vector control and surveillance will remain critical.— Dr. Gagandeep Kang, former professor, Christian Medical College in Vellore
A Conversa do Hearth Outra perspectiva sobre a história
Why did Sharma's case surprise him so much? Wasn't dengue always a risk?
Because the disease had a rhythm everyone relied on. You got dengue during monsoon season or shortly after. If you had a fever in April, you didn't think dengue. That certainty is gone now.
What changed? Did the virus mutate?
Not exactly. The virus didn't change its nature. The world around it did. Warmer temperatures, erratic rainfall, cities expanding into areas where mosquitoes breed. The mosquitoes are surviving longer and spreading farther than they used to.
So this is a climate story, not a disease story.
It's both. Climate creates the conditions, but the disease exploits them. And there's another layer—air pollution. Countries with dirtier air see dengue deaths three to five times higher than cleaner countries. The virus doesn't care about pollution, but weakened immune systems do.
Is the vaccine going to fix this?
It will help, but it's not a fix. You still need mosquito control, surveillance, sanitation. A vaccine is one tool in a much larger system that has to work together.
What does Sharma do now?
He's become hypervigilant. Repellents year-round. Checking water containers constantly. He's living as if dengue could arrive any month. For him, the old seasonal calendar is obsolete.